#USA #ADC technology #Piramal Pharma #Riverview #Payload-Linker

Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO), has recently unveiled its latest innovative payload-linker suite located at its Riverview, Michigan facility. This significant milestone is part of a broader initiative driven by a $90 million investment aimed at expanding U.S.-based manufacturing capabilities.

The new suite enhances the company's existing services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), positioning Piramal to better support the development and production processes for complex therapies such as antibody-drug conjugates (ADCs) and other bioconjugates. Peter DeYoung, CEO of Piramal Global Pharma, emphasized the importance of this launch, stating, "The suite places world-class expertise, advanced technology, and commercial-scale payload-linker capabilities right here in Michigan, empowering our customers to accelerate the development and delivery of life-changing therapies, like ADCs."

A Commitment to U.S.-Based Innovation

The establishment of the payload-linker suite is a testament to Piramal's commitment to U.S.-based innovation and manufacturing. This move ensures that partners can enjoy unmatched efficiency and supply chain security while benefiting from a seamless transition from concept to clinical application.

With over six decades of experience, the Riverview facility has established itself as a leader in drug substance development and manufacturing. The site is equipped with specialized knowledge in HPAPIs, making it a crucial supplier in the ADCelerate™ program—Piramal's rapid, integrated approach to early-phase ADC development. The addition of the payload-linker suite will not only help cut down development timelines but also adapt to changing market demands, indicating a proactive approach from Piramal Pharma Solutions.

Advanced Technology Meets Strategic Planning

This state-of-the-art facility is outfitted with advanced containment, automation, and analytical technologies. These features ensure a seamless process for scaling payload-linker programs effectively, further strengthening the ADCelerate™ platform. The enhancements across both the Riverview and Lexington facilities signify Piramal's strategic intent to be the preferred partner for companies aiming to innovate in the complex landscape of drug development and manufacturing.

Furthermore, this unveiling coincides with additional technological investments planned at Piramal's sterile injectables facility in Lexington, Kentucky. Such initiatives underscore the company’s commitment to staying at the forefront of biopharmaceutical development solutions.

A Holistic Approach to Drug Development

Piramal Pharma Solutions takes pride in its comprehensive approach to drug development and manufacturing. It offers end-to-end services across the drug lifecycle, supported by a globally integrated network that extends through North America, Europe, and Asia. By providing a diverse range of services—including drug discovery, process development, clinical trial supplies, and specialized services for bioconjugates—the company showcases its unmatched capabilities in fulfilling the needs of customer partners.

In addition to its advancements in manufacturing capabilities, Piramal Pharma Solutions also collaborates with its associate companies to further broaden its service offerings, including in the fields of biologics and gene therapies. Such strategic partnerships make Piramal a robust player in the pharmaceutical industry, solidifying its position not just as a service provider but as an innovator dedicated to expanding the frontiers of drug development.

Conclusion

The unveiling of the new payload-linker suite at Piramal Pharma Solutions' Riverview facility is indicative of a bright future for the company and its partners. With a focus on innovation, efficiency, and quality, Piramal continues to set the standard for excellence in the complex pharmaceutical landscape. As the industry progresses and the demand for advanced therapies increases, Piramal Pharma Solutions stands ready to meet the challenges head-on, ensuring timely deliveries of essential medical innovations to the market.